Form D · Pharmaceuticals
ResQ Pharma, Inc.
Glenview, IL · CIK 0001668333
Offering snapshot reported Dec 31, 2024 · SEC filing
- Reported sold
- $100K Offering amount: $100K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 27, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 31, 2024 | Initial | $99,999 | No comparison | 1 | SEC filing |
| Jun 16, 2022 | Initial | $205,501 | No comparison | 6 | SEC filing |
| Sep 10, 2020 | Initial | $1,020,000 | No comparison | 6 | SEC filing |
| Sep 16, 2016 | Initial | $739,500 | No comparison | 13 | SEC filing |
| Mar 2, 2016 | Initial | $325,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-533772
Source: Form D, filed Dec 31, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Todd Beck | Director, Executive, Promoter |
| David Bowman | Executive |
| Paul Burton | Director, Executive |
| Steve Bylina | Director, Executive, Promoter |
| Antoinette Gawin | Director, Executive, Promoter |
| Paul Hertz | Director, Executive, Promoter |
| Dominic O'keefe | Director, Executive, Promoter |
| Israel Rubinstein | Director |
| August H. Schupp | Director, Executive, Promoter |
| Joel Tune | Director, Executive, Promoter |
| Guy Weinberg | Director, Executive, Promoter |
| Francis Wisniewski | Director, Executive, Promoter |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2516 Waukegan Road Suite 375
Glenview, IL, 60025
Glenview, IL, 60025